Annual Non Current Assets
$42.54 B
+$16.58 B+63.87%
December 31, 2024
Summary
- As of February 7, 2025, NVO annual long term assets is $42.54 billion, with the most recent change of +$16.58 billion (+63.87%) on December 31, 2024.
- During the last 3 years, NVO annual non current assets has risen by +$25.96 billion (+156.56%).
- NVO annual non current assets is now at all-time high.
Performance
NVO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$42.54 B
+$12.24 B+40.40%
December 31, 2024
Summary
- As of February 7, 2025, NVO quarterly long term assets is $42.54 billion, with the most recent change of +$12.24 billion (+40.40%) on December 31, 2024.
- Over the past year, NVO quarterly non current assets has increased by +$14.99 billion (+54.43%).
- NVO quarterly non current assets is now at all-time high.
Performance
NVO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
NVO Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +63.9% | +54.4% |
3 y3 years | +156.6% | +156.6% |
5 y5 years | +349.3% | +349.3% |
NVO Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +156.6% | at high | +161.3% |
5 y | 5-year | at high | +349.3% | at high | +356.7% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $22.45 B(+8.3%) | $42.54 B(+40.4%) |
Sep 2024 | - | $30.30 B(+10.0%) |
Jun 2024 | - | $27.55 B(+4.3%) |
Mar 2024 | - | $26.40 B(+1.7%) |
Dec 2023 | $20.73 B(+33.1%) | $25.96 B(+16.1%) |
Sep 2023 | - | $22.36 B(+7.0%) |
Jun 2023 | - | $20.90 B(+4.9%) |
Mar 2023 | - | $19.92 B(+4.0%) |
Dec 2022 | $15.57 B(+19.5%) | $19.15 B(+17.5%) |
Sep 2022 | - | $16.30 B(+0.2%) |
Jun 2022 | - | $16.28 B(-1.9%) |
Mar 2022 | - | $16.60 B(+0.1%) |
Dec 2021 | $13.03 B(+19.8%) | $16.58 B(+28.2%) |
Sep 2021 | - | $12.93 B(-0.2%) |
Jun 2021 | - | $12.95 B(+2.7%) |
Mar 2021 | - | $12.61 B(-3.6%) |
Dec 2020 | $10.88 B(+16.2%) | $13.08 B(+25.1%) |
Sep 2020 | - | $10.45 B(+10.8%) |
Jun 2020 | - | $9.43 B(+1.3%) |
Mar 2020 | - | $9.31 B(-1.6%) |
Dec 2019 | $9.36 B(+3.5%) | $9.47 B(+5.0%) |
Sep 2019 | - | $9.01 B(-0.0%) |
Jun 2019 | - | $9.02 B(+4.5%) |
Mar 2019 | - | $8.63 B(+8.9%) |
Dec 2018 | $9.05 B(-6.5%) | $7.92 B(+6.6%) |
Sep 2018 | - | $7.43 B(+4.7%) |
Jun 2018 | - | $7.10 B(-1.6%) |
Mar 2018 | - | $7.22 B(+5.9%) |
Dec 2017 | $9.68 B(+13.9%) | $6.81 B(+5.5%) |
Sep 2017 | - | $6.46 B(+8.0%) |
Jun 2017 | - | $5.98 B(+7.9%) |
Mar 2017 | - | $5.54 B(+3.1%) |
Dec 2016 | $8.50 B(+5.2%) | $5.37 B(-0.2%) |
Sep 2016 | - | $5.38 B(+1.0%) |
Jun 2016 | - | $5.33 B(-2.6%) |
Mar 2016 | - | $5.47 B(+1.9%) |
Dec 2015 | $8.08 B(+6.9%) | $5.37 B(+5.6%) |
Sep 2015 | - | $5.08 B(-0.5%) |
Jun 2015 | - | $5.11 B(+3.6%) |
Mar 2015 | - | $4.93 B(-1.9%) |
Dec 2014 | $7.56 B(-2.9%) | $5.02 B(-2.1%) |
Sep 2014 | - | $5.13 B(-4.8%) |
Jun 2014 | - | $5.39 B(+1.9%) |
Mar 2014 | - | $5.29 B(+1.1%) |
Dec 2013 | $7.78 B(+9.4%) | $5.23 B(+6.3%) |
Sep 2013 | - | $4.93 B(+1.5%) |
Jun 2013 | - | $4.85 B(+5.9%) |
Mar 2013 | - | $4.58 B(+1.3%) |
Dec 2012 | $7.12 B(+3.2%) | $4.52 B(+1.5%) |
Sep 2012 | - | $4.45 B(+6.2%) |
Jun 2012 | - | $4.19 B(-5.7%) |
Mar 2012 | - | $4.45 B(+1.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $6.90 B(+3.7%) | $4.38 B(+3.2%) |
Sep 2011 | - | $4.24 B(-7.7%) |
Jun 2011 | - | $4.59 B(+3.0%) |
Mar 2011 | - | $4.45 B(+3.6%) |
Dec 2010 | $6.65 B(+5.9%) | $4.30 B(+1.2%) |
Sep 2010 | - | $4.25 B(+11.2%) |
Jun 2010 | - | $3.82 B(-7.5%) |
Mar 2010 | - | $4.13 B(-2.7%) |
Dec 2009 | $6.28 B(+14.9%) | $4.25 B(+0.0%) |
Sep 2009 | - | $4.25 B(+4.7%) |
Jun 2009 | - | $4.06 B(+5.9%) |
Mar 2009 | - | $3.83 B(-5.5%) |
Dec 2008 | $5.47 B(+14.9%) | $4.05 B(-1.7%) |
Sep 2008 | - | $4.12 B(-12.3%) |
Jun 2008 | - | $4.70 B(-2.2%) |
Mar 2008 | - | $4.81 B(+4.8%) |
Dec 2007 | $4.76 B(+29.1%) | $4.59 B(-4.7%) |
Sep 2007 | - | $4.81 B(+4.3%) |
Jun 2007 | - | $4.62 B(+8.2%) |
Mar 2007 | - | $4.27 B(+1.1%) |
Dec 2006 | $3.69 B(+19.0%) | $4.22 B(+6.8%) |
Sep 2006 | - | $3.95 B(+1.0%) |
Jun 2006 | - | $3.91 B(+7.4%) |
Mar 2006 | - | $3.64 B(+2.6%) |
Dec 2005 | $3.10 B(-4.8%) | $3.55 B(+0.1%) |
Sep 2005 | - | $3.54 B(+4.3%) |
Jun 2005 | - | $3.40 B(-3.3%) |
Mar 2005 | - | $3.51 B(-2.6%) |
Dec 2004 | $3.25 B(+18.0%) | $3.61 B(+13.5%) |
Sep 2004 | - | $3.18 B(+3.7%) |
Jun 2004 | - | $3.06 B(+0.5%) |
Mar 2004 | - | $3.05 B(-0.9%) |
Dec 2003 | $2.76 B(+42.0%) | $3.08 B(+23.1%) |
Dec 2002 | $1.94 B(+18.5%) | $2.50 B(+40.5%) |
Dec 2001 | $1.64 B(+4.9%) | $1.78 B(+18.2%) |
Dec 2000 | $1.56 B(-7.5%) | $1.50 B(+5.3%) |
Dec 1999 | $1.69 B(-17.4%) | $1.43 B(-36.1%) |
Dec 1998 | $2.05 B(+8.6%) | $2.24 B(+18.7%) |
Dec 1997 | $1.88 B(+1.9%) | $1.88 B(-0.9%) |
Dec 1996 | $1.85 B(+6.5%) | $1.90 B(+0.4%) |
Dec 1995 | $1.74 B(-20.0%) | $1.89 B(+45.3%) |
Dec 1994 | $2.17 B(+59.7%) | $1.30 B(-12.1%) |
Dec 1993 | $1.36 B(-19.6%) | $1.48 B(+49.7%) |
Dec 1992 | $1.69 B(+17.8%) | $990.68 M(-13.7%) |
Dec 1991 | $1.44 B(+25.0%) | $1.15 B(+13.2%) |
Dec 1990 | $1.15 B(+18.8%) | $1.01 B(+27.3%) |
Dec 1989 | $966.37 M(+36.0%) | $796.27 M(+26.4%) |
Dec 1988 | $710.80 M(+3.5%) | $629.89 M(-5.7%) |
Dec 1987 | $687.01 M(+16.1%) | $667.63 M(+29.1%) |
Dec 1986 | $591.69 M(+23.7%) | $517.16 M(+51.0%) |
Dec 1985 | $478.19 M(+24.8%) | $342.58 M(+45.0%) |
Dec 1984 | $383.03 M | $236.30 M |
FAQ
- What is Novo Nordisk A/S annual long term assets?
- What is the all time high annual non current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual non current assets year-on-year change?
- What is Novo Nordisk A/S quarterly long term assets?
- What is the all time high quarterly non current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly non current assets year-on-year change?
What is Novo Nordisk A/S annual long term assets?
The current annual non current assets of NVO is $42.54 B
What is the all time high annual non current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual long term assets is $42.54 B
What is Novo Nordisk A/S annual non current assets year-on-year change?
Over the past year, NVO annual long term assets has changed by +$16.58 B (+63.87%)
What is Novo Nordisk A/S quarterly long term assets?
The current quarterly non current assets of NVO is $42.54 B
What is the all time high quarterly non current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly long term assets is $42.54 B
What is Novo Nordisk A/S quarterly non current assets year-on-year change?
Over the past year, NVO quarterly long term assets has changed by +$14.99 B (+54.43%)